MedTrace Logo

MyDiabby Healthcare Vs Diary in Gestational Diabetes Mellitus.

NCT05510583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 668

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of the study is to demonstrate the non-inferiority of the onset of maternal, foetal, and neonatal complications for patients who had Gestational diabetes mellitus (GDM) and who had been monitored by myDiabby Healthcare compared to patients who had a classic glycemic blood monitoring by diary

Conditions

  • Gestational Diabetes

Interventions

OTHER

Control group

Retrospective study on pregnant women (≥18 years) with gestational diabetes who gave birth between 01/01/2013 and 30/06/2015. Patients received traditional paper-based blood glucose monitoring.

OTHER

Treated group

Retrospective study on pregnant women (≥18 years) with gestational diabetes who gave birth between 01/01/2021 and 31/12/2021. Patients received remote monitoring with myDiabby Healthcare

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Pr Christophe Poncelet · Hôpital NOVO

  • Dr Catherine Campinos · Hôpital NOVO

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-02
Primary Completion
2023-04-17
Completion
2023-04-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05510583 on ClinicalTrials.gov